Novavax
- Market cap
- 1.85B
- P/E (TTM)i
- -8.31
- P/Bi
- -9.71
- EPSi
- 2.58
- Div yieldi
- 0.00%
- 52W posi
- 70%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Novavax closed at 11.22, down 0.88%. The company carries a market value of roughly 1.85B, the #2865 most valuable US-listed company we track. Across 3 analysts the consensus rating is Hold, with an average price target of 11.33 (+1%). The shares sit 70% of the way up their 52-week range of 6.20 to 13.39.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 month.
- Recent price momentum is +20.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Hold.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 11.32
- Open
- 11.01
- Day range
- 10.90 - 11.75
- Avg price
- 11.35
- Volume
- 8.38M
- Turnover
- 95.11M
- Turnover ratei
- 5.88%
- Volume ratioi
- 0.70
- Amplitudei
- 7.51%
- 52-week rangei
- 6.20 - 13.39
Valuation
- P/Ei
- 4.35
- P/E (TTM)i
- -8.31
- P/Bi
- -9.71
- EPSi
- 2.58
- Book value / shi
- -1.16
- Net profit
- 425.56M
- Net assets
- -190.68M
Share structure
- Market cap
- 1.85B
- Float capi
- 1.60B
- Shares out
- 164.95M
- Float sharesi
- 142.58M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
16.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-10.61M net over the window
Short interest
- Shares short
- 49.88M
- % of floati
- 30.24%
- Days to coveri
- 9.28
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Novavax (NVAX)?
Novavax last traded at 11.22. The quote on this page refreshes every few seconds while US markets are open.
What is Novavax's market cap?
About 1.85B.
What is the P/E ratio of Novavax?
The trailing twelve-month P/E is -8.31. The Valuation tab shows it against the stock's own five-year range.
Does Novavax pay a dividend?
Novavax does not currently pay a regular dividend.
Is Novavax a buy according to analysts?
The consensus of 3 analysts is a Hold rating, with an average 12-month price target of 11.33, which implies 1.0% upside from the current price. This is not investment advice.
What is Novavax's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Novavax a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 06:47:28 · For reference only, not investment advice and not tailored to your situation.